Literature DB >> 9007058

Complementation of defective picornavirus internal ribosome entry site (IRES) elements by the coexpression of fragments of the IRES.

L O Roberts1, G J Belsham.   

Abstract

Mutant forms of the encephalomyocarditis virus (EMCV) internal ribosome entry site (IRES) have been produced and shown to be severely defective in directing internal initiation of protein synthesis within cells using the vaccinia/T7 RNA polymerase system. Mutants in different regions of the IRES were complemented in trans by coexpression of the intact EMCV IRES but not by coexpression of the related IRES elements from Theiler's murine encephalomyelitis virus (another cardiovirus) or from foot-and-mouth disease virus. Distinct, truncated regions of the EMCV IRES, insufficient to direct internal initiation, were also shown to complement defective EMCV IRES elements. It was necessary for the complementing molecule, whether truncated or full length, to be expressed in the positive sense orientation. RT-PCR analysis provided no support for the idea that any recombination event was responsible for the complementation. The data suggest that multiple activities are performed by distinct functional entities within the IRES in the process of internal initiation of protein synthesis. At least some of these different functions may be achieved by different molecules acting in trans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9007058     DOI: 10.1006/viro.1996.8312

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  A selection system for functional internal ribosome entry site (IRES) elements: analysis of the requirement for a conserved GNRA tetraloop in the encephalomyocarditis virus IRES.

Authors:  M E Robertson; R A Seamons; G J Belsham
Journal:  RNA       Date:  1999-09       Impact factor: 4.942

2.  Novel fluorescence-based screen to identify small synthetic internal ribosome entry site elements.

Authors:  A Venkatesan; A Dasgupta
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

3.  Recognition of picornavirus internal ribosome entry sites within cells; influence of cellular and viral proteins.

Authors:  L O Roberts; R A Seamons; G J Belsham
Journal:  RNA       Date:  1998-05       Impact factor: 4.942

4.  Monocistronic mRNAs containing defective hepatitis C virus-like picornavirus internal ribosome entry site elements in their 5' untranslated regions are efficiently translated in cells by a cap-dependent mechanism.

Authors:  Graham J Belsham; Inge Nielsen; Preben Normann; Elizabeth Royall; Lisa O Roberts
Journal:  RNA       Date:  2008-06-20       Impact factor: 4.942

5.  Tailoring the switch from IRES-dependent to 5'-end-dependent translation with the RNase P ribozyme.

Authors:  Noemi Fernández; Encarnación Martínez-Salas
Journal:  RNA       Date:  2010-03-01       Impact factor: 4.942

6.  Long-range RNA interactions between structural domains of the aphthovirus internal ribosome entry site (IRES).

Authors:  R Ramos; E Martínez-Salas
Journal:  RNA       Date:  1999-10       Impact factor: 4.942

7.  Mg2+ modulation of EMCV IRES key activity fragment equilibria and r(G*C) base-pair kinetics.

Authors:  J A Dupont; K Snoussi
Journal:  J Biol Phys       Date:  2009-04-29       Impact factor: 1.365

8.  A novel protein-RNA binding assay: functional interactions of the foot-and-mouth disease virus internal ribosome entry site with cellular proteins.

Authors:  I A Stassinopoulos; G J Belsham
Journal:  RNA       Date:  2001-01       Impact factor: 4.942

9.  NMR studies of the structure and Mg2+ binding properties of a conserved RNA motif of EMCV picornavirus IRES element.

Authors:  Marie Phelan; Ryan J Banks; Graeme Conn; Vasudevan Ramesh
Journal:  Nucleic Acids Res       Date:  2004-09-07       Impact factor: 16.971

10.  Presence of an encephalomyocarditis virus internal ribosome entry site sequence in avian infectious bronchitis virus defective RNAs abolishes rescue by helper virus.

Authors:  Brian Dove; David Cavanagh; Paul Britton
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.